Myriad Genetics Inc. (MYGN)
NASDAQ · Healthcare
Myriad Genetics Inc. Income Statement 2009–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | Jun 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||||
| Revenue | 824.5M | 837.6M | 753.2M | 678.4M | 690.6M | 557.1M | 638.6M | 851.1M | 743.7M | 728.7M | 740.5M | 722.5M | 778.2M | 613.2M | 496.0M | 402.1M | 362.6M | 326.5M |
| Gross Profit | 576.6M | 585.4M | 517.0M | 476.4M | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Profitability | ||||||||||||||||||
| Operating Income | -387.2M | -123.5M | -257.4M | -140.6M | -190.5M | -289.7M | -231.7M | 7.6M | 121.9M | 44.0M | 153.4M | 133.6M | 274.4M | 228.0M | 180.3M | 157.8M | 135.1M | 126.5M |
| EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | -365.9M | -127.3M | -263.3M | -112.0M | -27.2M | -223.6M | -199.5M | 4.6M | 133.3M | 17.4M | 117.2M | 79.8M | 176.2M | 147.2M | 112.2M | 100.7M | 152.3M | 84.6M |
| Per Share Data | ||||||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 93M | 91M | 83M | 81M | 78M | 75M | 74M | 76M | 72M | 69M | 73M | 75M | 78M | 83M | 86M | 92M | 99M | 99M |
Myriad Genetics Inc. Income Statement — FAQ
Myriad Genetics Inc. (MYGN) income statement over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MYGN's income statement history?
The chart and table above show Myriad Genetics Inc.'s income statement by year and by quarter, including the growth rate.